Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

As researchers and healthcare professionals seek new ways to tackle chronic diseases, targeted approaches like this one could ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

GSK's (GSK) linerixibat achieves significant itch reduction in a late-stage trial for cholestatic pruritus, meeting key goals ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Treatments Market" report has been added to ResearchAndMarkets.com's offering. The global market for liver disease treatments is ...

An experimental new treatment is showing early promise in the fight against liver fibrosis - a serious and often silent condition that affects around ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...